We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
4DMedical could replicate Pro Medicus’ US success Its new tech could revolutionise lung disease dia...
Read ArticleIn today’s Australian market, several companies have demonstrated remarkable gains, reflecting a rob...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe cannabis industry is poised for growth, driven by evolving legalisation globally Investment opp...
Read ArticleASX 200 ends a weak day down but not way down… just -0.23pc All 11 sectors were generally terrible...
Read ArticleNot much in the way of headline news, but the market plodded along ASX 200 closes down -0.12pc, des...
Read ArticleImricor completes installation of iCMR capital equipment at Lausanne University Hospital in Switzer...
Read ArticleSeveral ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
Read ArticleSince TGA’s down-scheduling of CBD last year, no products have been sold in Australia But the race...
Read ArticleZelira announced that its diabetic nerve pain drug outperforms Pfizer’s Lyrica Diabetes is a huge m...
Read ArticleThe weed industry has slumped as it faces several headwinds But new data suggests the industry will...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleThe world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosiv...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe S&P ASX 200 was down 2.5% in May, with mid caps performing the best and small caps lagging...
Read ArticleCannabinoid company Zelira Therapeutics (ASX:ZLD) has announced the appointment of Dr Donna...
Read ArticleThe ASX 200 fell 1.37%, and the bad news kept piling up all day Inflation data knee-capped the mark...
Read ArticleThe market closed lower today, with the ASX 200 down 1.6 per cent to 7,091.3 points. Inflation fo...
Read ArticleIt’s been a pretty miserable day on the ASX share market this Wednesday. The All Ordinaries Index (...
Read ArticleStockhead’s In-Case-You-Missed-It highlights some of the strongest performing ASX stocks that might...
Read ArticleShares in Perth-based medical cannabinoid developer Zelira Therapeutics’ (ASX: ZLD) rocketed by than...
Read ArticleThis content is created by Smallcaps Authors. [Author : Imelda Cotton] Perth-based Zelira Therapeu...
Read ArticleZelira skyrockets by almost 200% this morning The company said its drug could work better than Lyri...
Read ArticleEarly 1.37% benchmark jump slides slowly to land at +0.88% Real Estate leads on +1.89%, with Consum...
Read ArticleThe Swiss government has moved quickly to shore up its uniqueness as a centre of commerce – albeit o...
Read ArticleZelira Therapeutics (ZLD) raises $1.77 million to progress its clinical trials The funds were rai...
Read ArticleASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index...
Read ArticleTwitter to allow cannabis companies to advertise in US states where it’s legal Elixnol comes out on...
Read ArticleThe ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month...
Read ArticleZelira Therapeutics (ZLD) promotes Greg Blake to the role of Executive Director Mr Blake joined t...
Read ArticleZelira Therapeutics (ZLD) secures US$8.6 million (A$12.3 million) in cornerstone funding from a US-b...
Read ArticleThe ASX 200 fell 0.21% and the ASX XEC slips 1.05% A 8 out of 11 sectors were lower led by Consumer...
Read ArticleZelira Therapeutics (ASX:ZLD) has announced the successful enrolment of 60 patients in the c...
Read ArticleCambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown...
Read ArticleZelira Therapeutics (ZLD) completes enrolment of two-thirds of patients for its diabetic nerve pain...
Read ArticleThe ASX will rise modestly higher on Thursday Wall Street whipsawed in a volatile day of trading Au...
Read ArticleJust over a month after the collapse of Health House International’s (ASX: HHI) proposed merger with...
Read ArticleBenchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back...
Read ArticleECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensa...
Read ArticleThe ASX 200 is up, the XEC is up solidly Energy, resources, materials are back in black US CPI w...
Read ArticleItâs another green day for the Zelira Therapeutics Ltd (ASX: ZLD) share price. The medicinal cann...
Read ArticleZelira Therapeutics (ZLD) receives formal approval from the German regulatory authority BfArM for t...
Read ArticleThe Zelira Therapeutics Ltd (ASX: ZLD) share price has exploded in the past two days. This ASX med...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleThe Zelira Therapeutics Ltd (ASX: ZLD) share price was put on ice in mid-afternoon trading on Tue...
Read ArticleThe ASX 200 ends flat, XEC sheds 1.6% Gains in healthcare and supermarkets offsets losses for miner...
Read ArticleRetail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufa...
Read ArticleA "substantial change in market conditions" is behind a mutual decision to terminate a merger of Zel...
Read ArticleZelira Therapeutics (ZLD) mutually agrees to terminate a deal with Health House International In Fe...
Read ArticleEmerging Companies (XEC) index dives 2.6% Benchmark ASX200 down 0.6% Culpeo Minerals meets copper,...
Read ArticleA Thai university says adding cannabis to chicken feed has positive results on meat and egg quality...
Read ArticleZelira Therapeutic’s (ZLD) share price is on the rise after releasing results of its study on its Z...
Read ArticleASX set to open higher today despite rising rate risks Tech leads Wall Street overnight Goldman pre...
Read ArticleOver the past decade, opioid-induced deaths were more likely to be due to prescription drugs than i...
Read ArticleZelira Therapeutics (ZLD) completes enrolment for its diabetic nerve pain drug trial The trial will...
Read ArticleInvion demonstrates high efficacy of INV043 when used as a combined therapy Biotron gets positive f...
Read ArticleActor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wel...
Read ArticleNyrada’s European patent submission gets a patent number Zelira’s positive study results on its aut...
Read ArticleASX to open higher as Wall Street returns a mixed bag Oil prices are higher by 3% El Salvador to ho...
Read ArticleUS Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax...
Read ArticleZelira Therapeutics (ASX:ZLD) has announced it has executed a binding scheme implementation...
Read ArticleHemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The leg...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200...
Read ArticleZelira Therapeutics (ZLD) is set to take over Health House International to expand the market reach...
Read ArticleZelira Therapeutics (ASX:ZLD), a company focused on the development of clinically validated...
Read ArticleImmuron nabs $6.2m clinical research deal for US Military strength Travelan dose ECS Botanics repor...
Read ArticleZelira Therapeutics (ZLD) has received a $1.29 million cash refund under the Federal Government’s r...
Read ArticleZelira Therapeutics (ZLD) has received US$250,000 (A$348,000) for its technology which enables the...
Read ArticleZelira Therapeutics (ZLD) expands into the New Zealand cannabinoid-based medicines market via a fiv...
Read ArticleThe ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broa...
Read ArticleWall Street rallies on Fed decision US stocks rallied strongly overnight, as investors digested the...
Read ArticleZelira Therapeutics (ASX:ZLD) has announced ethics approval has been granted for the Phase 2...
Read ArticleZelira Therapeutics (ZLD) receives ethics approval for its Phase 2a clinical trial for chronic pain...
Read ArticleZelira Therapeutics (ZLD) signs a licensing deal for its Enhanced Distillate Capture and Dissolutio...
Read ArticleFresh record highs on Wall Street ahead of Fed statement US stocks continued their strong recent run...
Read ArticleAs the world emerges from the pandemic, markets are now contending with an energy crisis, a global s...
Read ArticleZelira Therapeutics (ZLD) raises US$5 million (around A$6.69) from US family office fund, Quincy St...
Read ArticleJust like yesterday the ASX rallied for most of the day but retreated in the afternoon and today clo...
Read ArticleZelira Therapeutics (ZLD) calls a two-day trading halt as it gears up to raise some fresh funds The...
Read ArticleRetail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired f...
Read ArticleWall Street higher as US Fed firms up November tapering US stock markets were higher overnight, as U...
Read ArticleWall Street slips as iron ore falls further All three US stock market indexes fell on Friday, ahead...
Read ArticleShareCafeHidden Gems Webinar Recap – ZLD, WTL, AGN, CLA Catch up on the full webinar with presenta...
Read ArticleWall Street at fresh record highs All three key US benchmarks rose and reached fresh record highs on...
Read ArticleThe 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX:...
Read ArticleCannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Me...
Read ArticleConnecticut has become the latest US state to legalise recreational use of marijuana. The state’s go...
Read ArticleThe US cannabis sector received a big lift after Amazon announced that job applicants at its offices...
Read ArticleThe ASX 200 just closed 0.92 per cent up at 7,380 points — a new record high. The ASX Emerging Com...
Read ArticleWall Street mixed ahead as Nasdaq hits record highs Major indices in the US were mixed on Monday, wi...
Read ArticleThe medicinal cannabis industry is gaining significant momentum, however, still remains in the early...
Read ArticleSummary Hillgrove Resources’ share price has skyrocketed 64.8% today and is currently trading at...
Read ArticleSummary Diagnostics company Rhythm Biosciences has confirmed that LRF enhancements have shown to...
Read ArticleThe Zelira Therapeutics Ltd (ASX: ZLD) share price is firmly in the green today following a positiv...
Read ArticleDow Jones at record level, as US tech stocks sell off again The Dow Jones index has reached its all-...
Read ArticleSummary ASX-listed Splitit Payments Limited announced strong growth in Merchant Sales Volume (MS...
Read ArticleThe Zelira Therapeutics Ltd (ASX: ZLD) share price is lower during mid-afternoon trade despite anno...
Read ArticleZelira Therapeutics (ASX:ZLD) says it generated record quarterly product sales and licensing...
Read ArticleWall Street mixed, even as banks’ earnings beat estimates US investors took the strong banks’ earnin...
Read ArticleIn what may be a catalyst for ASX cannabis shares, a private company today gained approval to grow...
Read ArticleAustralia has one of the highest rates of household pet ownership in the world. The RSPCA estimates...
Read ArticleThere is a sector in Australia that’s about to grow its revenue by 478% in the current financial ye...
Read ArticleInvestors in ASX cannabis shares have had a bumpy ride in 2020. Share prices were impacted by globa...
Read ArticleThe share price of medical cannabis company Zelira Therapeutics Ltd (ASX:ZLD) has rocketed today tha...
Read ArticleThe Zelira Therapeutics Ltd (ASX: ZLD) share price is breaking new records today. This comes after...
Read ArticleShares in Zelira Therapeutics (ASX:ZLD) have risen more than 30 per cent to a nearly two-year high i...
Read ArticleSummary During September quarter, Zelira Therapeutics achieved significant milestones marking it...
Read ArticleSummary Zelira Therapeutics forays into the US oral care market by launching CBD toothpaste in p...
Read ArticleSummary Leading biopharmaceutical company Zelira Therapeutics signed an agreement with Emyria Lt...
Read ArticleHaving been subject to a harsh reality check over the last year or so, the ASX-listed cannabis secto...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleListed cannabis company Zelira Therapeutics (ASX: ZLD) has today formed a new Oral Care products sub...
Read ArticleListed cannabis company Zelira Therapeutics (ASX: ZLD) has today formed a new Oral Care products sub...
Read Article08 Sep 2020 - Global therapeutic medicinal cannabis company, Zelira Therapeutics (ASX:ZLD) has expan...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleStockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up th...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleZelira (ASX: ZLD) has partnered with US-based Cardiovascular Solutions of Central Mississippi (CVSCM...
Read ArticleMedical cannabis company Zelira Therapeutics (ASX: ZLD) has committed to a binding five-year agreeme...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleZelira Therapeutics (ASX:ZLD) has completed another medicinal cannabis trial and passed with flying...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSince the start of March, six clinical trials involving cannabis treatments around the world have be...
Read ArticleAustralian medicinal cannabis company Zelira Therapeutics (ASX:ZLD) has announced a commerci...
Read ArticlePerth-based medicinal cannabis company Zelira Therapeutics (ASX:ZLD) has announced it has de...
Read ArticleZelira Therapeutics (ASX: ZLD) has announced its Phase 1b/2a medicinal cannabis trial to treat insom...
Read ArticleIn proof that biotechs will deliver market returns even during a pandemic, two companies this mornin...
Read ArticleZelira Therapeutics (ASX:ZLD) chief Dr Richard Hopkins confirms what your columnist suspected was a...
Read ArticleMedicinal cannabis company Zelira Therapeutics (ASX:ZLD) says its Phase 1 Dose Escalation Tr...
Read ArticleLittle Green Pharma (ASX:LGP) announced a new export partner — and it happens to be the only company...
Read ArticleTwo years ago Zelira (ASX:ZLD) — then Zelda — was set to invade the German market, planning to storm...
Read ArticleAnother ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its product...
Read ArticleMedicinal cannabis company Zelira Therapeutics (ASX:ZLD) has completed a placement of 91,770...
Read ArticleTherapeutic medicinal cannabis company, Zelira Therapeutics (ZLD) has successfully completed a $4.5...
Read ArticleElixinol Global (ASX:EXL) is bleeding money and is holding a fire sale of its global hemp and medica...
Read ArticleQuarterly reports for biotechs usually only tell investors how much cash they have left — and how mu...
Read ArticleZelira Therapeutics (ASX:ZLD) has announced a collaboration with the US-based Parkinson’s Fo...
Read ArticleOnly one prescription for medical marijuana has been issued by a doctor in the Northern Territory, a...
Read ArticleFor an industry that’s projected to reach $US20 billion ($29 billion) by 2024 in the US, the cannabi...
Read ArticleThere are many reasons why a company might change its name, from being taken over to hiding a shady...
Read ArticleMarijuana is the hottest herb on the planet right now, but while investing in medical cannabis stock...
Read ArticleAn Initial Public Offering (IPO) is a process in which a private company offers its shares to the pu...
Read ArticleZelira Therapeutics Limited (ASX: ZLD) has announced that last patient has completed dosing in its p...
Read ArticleNew Zealand’s medicines regulator has recommended the country fall in line with Australia’s new code...
Read Article05 Dec 2019 - Zelda Therapeutics (ASX:ZLD) has confirmed the company has changed its name to Zelira...
Read ArticlePot stock THC Global (ASX:THC) is in business at Southport, the largest medicinal cannabis productio...
Read ArticleThe THC Global Group Ltd (ASX: THC) share price has returned from its trading halt and surged highe...
Read ArticleZelira Therapeutics, formerly known as Zelda Therapeutics (ASX:ZLD), has announced the compl...
Read ArticleZelda Therapeutics’ (ASX: ZLD) medicinal cannabis products will be distributed across Australasia an...
Read ArticleThis is a strategic and non-exclusive agreement which opens the door into some of the world’s fastes...
Read ArticleThailand has not yet legalised marijuana but pretty soon Thais will not only be able to grow their o...
Read ArticleZelda recently detailed its intention to merge with Ilera Therapeutics to create a leading medicinal...
Read ArticleZelda will be one of several suppliers in the clinical trial seeking to enrol up to 600 advanced can...
Read ArticleZelda Therapeutics (ASX:ZLD) has entered a new agreement with the NHMRC-funded Australian Ce...
Read ArticleThe tax refund will be used on the cannabinoid-based therapeutics developer’s program as it plans pr...
Read ArticleThe pioneering medicinal cannabis clinical trial for insomnia is treating 24 patients at the Univers...
Read ArticleMedicinal cannabis company Zelda Therapeutics (ASX:ZLD) has announced that its clinical tria...
Read ArticleDrug delivery specialist SUDA Pharmaceuticals (ASX: SUD) has finalised a deal with medical cannabis...
Read ArticleFor a while there, it seemed like the Australian cannabis sector had stalled. Not only were many can...
Read ArticleStrong gains among selected life science shares is fuelling optimism the sector may have further to...
Read ArticleCurrent Zelda Therapeutics (ASX:ZLD) boss Dr Richard Hopkins cut an animated figure at a media brief...
Read ArticleTwo and a half years ago, cannabis was so hot Stemcell United (ASX:SCU) went from 1 cent to 19 cents...
Read ArticleThe merger will bring together a leading pipeline of clinical candidates, revenue-generating medicin...
Read ArticleZelda Therapeutics Ltd, Zelda Therapeutics news, Zelda Therapeutics share price, Zelda Therapeutics...
Read ArticleCannabis company Zelda Therapeutics Ltd (ASX: ZLD) has seen its share price push higher today after...
Read ArticleMajor Australian medical cannabis group Zelda Therapeutics (ASX: ZLD) has announced a landmark merge...
Read ArticleMedicinal cannabis company Zelda Therapeutics has announced a "merger of equals" with privat...
Read ArticleOn Stockhead today: five water treatment stocks surge 260 per cent in a year, the ASX’s most intrigu...
Read ArticleThe company’s securities will remain in a trading halt until the beginning of trade on October 10 or...
Read ArticleKicking back at your favourite cafe and smoking a joint is an activity historically associated with...
Read ArticleYou may have heard about an opioid crisis over in the US; it was declared a public health emergency...
Read ArticleDrugs intake in the form of pills, capsules, and tablets are not the most efficient ways of taking m...
Read ArticleCannabis was once synonymous with drugs, marijuana, ill-health and the scourges of our society. Pres...
Read ArticleWith growing focus of governments across the globe on legalising recreational and medicinal cannabis...
Read Article‘Pot stocks’ were making headlines in 2018. California, one of the world’s biggest economies and th...
Read ArticleParents of more than 100 kids aged about 10 are reporting how the treatments affect the children’s b...
Read ArticleSUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the life...
Read ArticleThe healthcare industry of Australia is a key contributor in developing the economy. The companies w...
Read ArticleTo increase the bioavailability of administered medications, Australian-headquartered SUDA Pharmaceu...
Read ArticleAustralia has established its strong position in the contemporary world that is welcoming the good s...
Read ArticleThe federal government has taken steps to cut red tape and speed up the granting of licences for Aus...
Read ArticleZelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results f...
Read ArticleToday, we hear from Maxim Jacobs, managing partner at New York-based Edison Investment Research. W...
Read ArticleAn oro-mucosal drug delivery company headquartered in Perth, SUDA Pharmaceuticals Ltd (ASX: SUD) use...
Read ArticleA new chain of medical cannabis clinics are set to roll out across Australia as part of a collaborat...
Read ArticleZelda Therapeutics (ASX:ZLD) has entered a strategic collaboration with Australian-based Eme...
Read ArticleStem cell manufacturer Cynata Therapeutics (ASX: CYP) has announced this morning it has received an...
Read ArticleThe agreement supports Zelda’s path to rapid commercialisation through the development of clinically...
Read ArticleTaking the cannabis market to the next level, the US is now taking a closer look at the industry’s l...
Read ArticleThe Australian bio-pharmaceutical company is developing proprietary cannabinoid formulations to trea...
Read ArticleAs the cannabis sector gains momentum in Australia and given that medicinal cannabis was legalised i...
Read ArticleCalifornian cannabis company Caliva has signed on billionaire rapper Shawn “Jay-Z” Carter to promote...
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read ArticleThe cannabis market is expected to grow multi-fold in the next decade, given the legalisation of Can...
Read ArticleThe ASX’s 32 tradeable pot stocks and pot stock wannabees are down 17 per cent over the last 12 mont...
Read ArticleDo you know that market enthusiasts believe that legalising cannabis would generate approximately $8...
Read ArticleZelda Therapeutics (ASX:ZLD) is no stranger to testing for positive health effects derived from medi...
Read ArticleThe phase I trial will begin immediately with preliminary results expected later this quarter and fu...
Read ArticleBio-pharmaceutical company Zelda Therapeutics (ASX: ZLD) has taken a decisive step towards mitigatin...
Read ArticleZelda Therapeutics (ASX:ZLD) has announced that its phase 1 Opioid Reduction Trial has been...
Read ArticleOne of Australia's leading cannabis companies Zelda Therapeutics (ASX: ZLD) has been given the green...
Read ArticleAustralian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Featur...
Read ArticleAustralian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Featur...
Read ArticleThe company’s medicinal cannabis products are aimed at treating pain, anxiety, sleep apnea and cance...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
